The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
BackgroundThe prognosis of high‐risk neuroblastoma patients has improved over the last decades. However, many patients experience relapse after successful initial treatment. We retrospectively analyzed the long‐term outcome of relapsed patients of three consecutive national neuroblastoma trials.
MethodsPatients were included when they fulfilled all of the following criteria: Age at diagnosis being...
Background
The majority of patients in low‐ and middle‐income countries (LMIC) are unable to receive optimal therapy, including autologous stem cell transplant (ASCT) for high‐risk neuroblastoma. Management is intensive and multidisciplinary; survival is often poor. We report a single‐center outcome of high‐risk neuroblastoma, with adaptations optimized for LMIC.
Procedure
The study was retrospective...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.